Use of progestogens in pregnancy and its maternal and fetal outcome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251224Keywords:
Luteal phase support, Miscarriage, Neonatal morbidity and mortality, Preterm birth, ProgesteroneAbstract
Background: Progesterone is a crucial hormone in the establishment and maintenance of pregnancy. In early pregnancy, progesterone is produced by the corpus luteum and suppresses the maternal immune system, enabling the embryo’s survival. Later in pregnancy, progesterone is produced by the placenta and plays a role in the relaxation of smooth muscle cells, ensuring myometrial quiescence until delivery.
Methods: A prospective randomized control trial was done on 100 pregnant women attending the OPD, after written informed consent from the patient, using SPSS software and satisfying the inclusion and exclusion criteria are taken and were grouped under A -Control group (50) in whom no treatment was given and B-Study group (50) in whom progesterone was given in the form of injection or tablet and followed up till delivery at Navodaya Medical College Research Centre, Raichur, India.
Results: There was statistically significant difference found between group A and B with respect to outcome of miscarriage and pre-term birth with p value 0.004 and 0.025 respectively. There was no statistically significant difference found between groups with respect to NICU admission/RDS.
Conclusions: The study concluded that progesterone is crucial for luteal phase support and maintaining pregnancy, reduces uterine contractility, thus preventing miscarriage, preterm birth and neonatal morbidity and mortality.
Metrics
References
Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S. Progesterone in normal and pathological pregnancy. Horm Mol Biol Clin Investig. 2016;27(1):35-48.
Czyzyk A, Podfigurna A, Genazzani AR, Meczekalski B. The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility. Gynecol Endocrinol. 2017;33(6):421-4. DOI: https://doi.org/10.1080/09513590.2017.1291615
Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 α-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85. DOI: https://doi.org/10.1056/NEJMoa035140
Di Renzo GC, Rosati A, Mattei A, Gojnic M, Gerli S. The changing role of progesterone in preterm labour. BJOG. 2005;112(Suppl 1):57-60.
Sundström-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone–friend or foe?. Fronti Neuroendocrinol. 2020;59:100856. DOI: https://doi.org/10.1016/j.yfrne.2020.100856
Rossato M, Nogara A, Merico M, Ferlin A, Foresta C. Identification of functional binding sites for progesterone in rat Leydig cell plasma membrane. Steroids. 1999;64(1-2):168-75. DOI: https://doi.org/10.1016/S0039-128X(98)00104-4
Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S. Progesterone in normal and pathological pregnancy. Hormone Mole Biol Clin Investigat. 2016;27(1):35-48. DOI: https://doi.org/10.1515/hmbci-2016-0038
Zakar T, Mesiano S. How does progesterone relax the uterus in pregnancy. N Engl J Med. 2011;364(10):972-3. DOI: https://doi.org/10.1056/NEJMcibr1100071
Walch KT, Huber JC. Progesterone for recurrent miscarriage: truth and deceptions. Best Pract Res Clin Obstetr Gynaecol. 2008;22(2):375-89. DOI: https://doi.org/10.1016/j.bpobgyn.2007.08.009
Taraborrelli S. Physiology, production and action of progesterone. Acta obstetricia et gynecologica Scandinavica. 2015;94:8-16. DOI: https://doi.org/10.1111/aogs.12771
Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E, Da Fonseca E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206:124.e1-124.
Daya S. Luteal support: progestogens for pregnancy protection. Maturitas 2009;65(Suppl 1):S29-S34. DOI: https://doi.org/10.1016/j.maturitas.2009.09.012
El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas. 2009;65(Suppl 1):S43-6. DOI: https://doi.org/10.1016/j.maturitas.2009.11.013
Di Renzo GC, Rosati A, Mattei A, Gojnic M, Gerli S. The changing role of progesterone in preterm labour. BJOG. 2005;112(Suppl 1):57-60. DOI: https://doi.org/10.1111/j.1471-0528.2005.00586.x
Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo controlled trial. Arch Gynecol Obstet 2011;283:423-9. DOI: https://doi.org/10.1007/s00404-009-1351-2
Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Ame J Obstetr Gynecol. 2012;206(2):124-e1. DOI: https://doi.org/10.1016/j.ajog.2011.12.003
Downloads
Published
How to Cite
Issue
Section
